Tumor-Selective, Futile Redox Cycle-Induced Bystander Effects Elicited by NQO1 Bioactivatable Radiosensitizing Drugs in Triple-Negative Breast Cancers

Aims: β-Lapachone (β-lap), a novel radiosensitizer with potent antitumor efficacy alone, selectively kills solid cancers that over-express NAD(P)H:quinone oxidoreductase 1 (NQO1). Since breast or other solid cancers have heterogeneous NQO1 expression, therapies that reduce the resistance (e.g., NQO1...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Cao, Lifen, Li, Long Shan, Spruell, Christopher, Xiao, Ling, Chakrabarti, Gaurab, Bey, Erik A., Reinicke, Kathryn E., Srougi, Melissa C., Moore, Zachary, Dong, Ying, Vo, Peggy, Kabbani, Wareef, Yang, Chin-Rang, Wang, Xiaoyu, Fattah, Farjana, Morales, Julio C., Motea, Edward A., Bornmann, William G., Yordy, John S., Boothman, David A.
Formato: Artigo
Idioma:Inglês
Publicado: Mary Ann Liebert, Inc. 2014
Assuntos:
Forum Original Research Communications
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4060774/
https://ncbi.nlm.nih.gov/pubmed/24512128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/ars.2013.5462
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares